Hyaluronan/RHAMM interactions in mesenchymal tumor pathogenesis: role of growth factors
- PMID: 25081535
- DOI: 10.1016/B978-0-12-800092-2.00012-5
Hyaluronan/RHAMM interactions in mesenchymal tumor pathogenesis: role of growth factors
Abstract
Fibrosarcoma belongs to the sarcoma cancer group, which are spindle cell malignancies of mesenchymal origin, and owe their name to the predominant cell line that is present within the tumor. The extracellular matrix (ECM) is a complicated structure that surrounds and supports cells within tissues. Its main components are proteoglycans, collagens, glycoproteins, hyaluronan (HA), and several matrix-degrading enzymes. During cancer progression, significant changes can be observed in the structural and mechanical properties of ECM components. The ECM provides a physical scaffold to which tumor cells attach and migrate. Thus, it is required for key cellular events such as cell motility, adhesion, proliferation, invasion, and metastasis. Importantly, fibrosarcomas were shown to have a high content and turnover of ECM components including HA, proteoglycans, collagens, fibronectin, and laminin. In this review, we will focus on the HA component of fibrosarcoma ECM and critically discuss its role and involved mechanisms during fibrosarcoma pathogenesis.
Keywords: Extracellular matrix; Fibrosarcoma; Growth factors; Hyaluronan; Rhamm.
© 2014 Elsevier Inc. All rights reserved.
Similar articles
-
The roles of hyaluronan/RHAMM/CD44 and their respective interactions along the insidious pathways of fibrosarcoma progression.Biomed Res Int. 2013;2013:929531. doi: 10.1155/2013/929531. Epub 2013 Sep 5. Biomed Res Int. 2013. PMID: 24083250 Free PMC article. Review.
-
Could growth factor-mediated extracellular matrix deposition and degradation offer the ground for directed pharmacological targeting in fibrosarcoma?Curr Med Chem. 2013;20(23):2868-80. doi: 10.2174/0929867311320230003. Curr Med Chem. 2013. PMID: 23597203 Review.
-
Role of receptor for hyaluronic acid-mediated motility (RHAMM) in low molecular weight hyaluronan (LMWHA)-mediated fibrosarcoma cell adhesion.J Biol Chem. 2011 Nov 4;286(44):38509-38520. doi: 10.1074/jbc.M111.275875. Epub 2011 Sep 13. J Biol Chem. 2011. PMID: 21914806 Free PMC article.
-
Receptor for hyaluronic acid- mediated motility (RHAMM) regulates HT1080 fibrosarcoma cell proliferation via a β-catenin/c-myc signaling axis.Biochim Biophys Acta. 2016 Apr;1860(4):814-24. doi: 10.1016/j.bbagen.2016.01.019. Epub 2016 Jan 26. Biochim Biophys Acta. 2016. PMID: 26825774
-
RHAMM/hyaluronan inhibit β-catenin degradation, enhance downstream signaling, and facilitate fibrosarcoma cell growth.Mol Biol Rep. 2023 Nov;50(11):8937-8947. doi: 10.1007/s11033-023-08763-0. Epub 2023 Sep 14. Mol Biol Rep. 2023. PMID: 37710072
Cited by
-
Hyaluronan and Reactive Oxygen Species Signaling-Novel Cues from the Matrix?Antioxidants (Basel). 2023 Mar 28;12(4):824. doi: 10.3390/antiox12040824. Antioxidants (Basel). 2023. PMID: 37107200 Free PMC article. Review.
-
HELLPAR/RRM2 axis related to HMMR as novel prognostic biomarker in gliomas.BMC Cancer. 2023 Feb 7;23(1):125. doi: 10.1186/s12885-023-10596-w. BMC Cancer. 2023. PMID: 36750807 Free PMC article.
-
Matrix Effectors in the Pathogenesis of Keratinocyte-Derived Carcinomas.Front Med (Lausanne). 2022 Apr 29;9:879500. doi: 10.3389/fmed.2022.879500. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35572966 Free PMC article. Review.
-
Systematic Analysis of the Clinical Significance of Hyaluronan-Mediated Motility Receptor in Colorectal Cancer.Front Mol Biosci. 2021 Oct 26;8:733271. doi: 10.3389/fmolb.2021.733271. eCollection 2021. Front Mol Biosci. 2021. PMID: 34765644 Free PMC article.
-
Inflammation, Extracellular Matrix Remodeling, and Proteostasis in Tumor Microenvironment.Int J Mol Sci. 2021 Jul 28;22(15):8102. doi: 10.3390/ijms22158102. Int J Mol Sci. 2021. PMID: 34360868 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
